(19)
(11) EP 4 429 653 A1

(12)

(43) Date of publication:
18.09.2024 Bulletin 2024/38

(21) Application number: 22893834.6

(22) Date of filing: 10.11.2022
(51) International Patent Classification (IPC): 
A61K 31/28(2006.01)
A61K 31/205(2006.01)
 C01G 39/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/28; A61K 31/495; A61K 31/122; A61K 45/06; A61K 33/00
 
C-Sets:
  1. A61K 31/495, A61K 2300/00;
  2. A61K 31/122, A61K 2300/00;
  3. A61K 33/00, A61K 2300/00;
(86) International application number:
PCT/US2022/079618
(87) International publication number:
WO 2023/086873 (19.05.2023 Gazette 2023/20)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 10.11.2021 US 202163277775 P

(71) Applicant: Reverspah LLC
Denver, CO 80204 (US)

(72) Inventors:
  • VOELKEL, Norbert, F.
    Denver, CO 80204 (US)
  • MAGOLSKE, Charles
    Denver, CO 80209 (US)
  • DORDUNOO, Stephen
    Halethorpe, MD 21227 (US)
  • KHINAST, Johannes
    810 Graz (AT)
  • EGLITE, Erik
    Lake Forest, IL 60045 (US)

(74) Representative: WSL Patentanwälte Partnerschaft mbB 
Kaiser-Friedrich-Ring 98
65185 Wiesbaden
65185 Wiesbaden (DE)

   


(54) METHODS AND COMPOSITIONS FOR TREATING CANCER